12.07.2015 Views

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

The Clinical Guide to Supportive and Palliative Care for HIV/AIDS

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A <strong>Clinical</strong> <strong>Guide</strong> <strong>to</strong> <strong>Supportive</strong> <strong>and</strong> <strong>Palliative</strong> <strong>Care</strong> <strong>for</strong> <strong>HIV</strong>/<strong>AIDS</strong> • Chapter 3: Assessment of Physical Symp<strong>to</strong>msSymp<strong>to</strong>m Assessment with Pediatric PatientsSymp<strong>to</strong>m assessment in children requires particular skill. Pediatric <strong>AIDS</strong> is a specializedarea <strong>and</strong>26discussedpicaselsewhere . 36 (See Chapter 12: <strong>The</strong> <strong>Care</strong> of Children <strong>and</strong> Adolescents.) Briefly,the age of the child <strong>and</strong> his or her ability <strong>to</strong> provide a report will influence the symp<strong>to</strong>m assessment.Older children who can provide answers <strong>to</strong> questions can be assessed with greater easethan younger children.<strong>Care</strong>ful attention <strong>to</strong> verbal cues <strong>and</strong> parental input is crucial in the pediatric population. Validatedmeasures <strong>for</strong> many symp<strong>to</strong>ms in this population are lacking, but a variety of measures have beendeveloped <strong>for</strong> the assessment of pain including visual analogue scales, “faces” scales, 37-42 <strong>and</strong>observational scales such as the Observational Scale of Behavioral Distress 43 <strong>and</strong> the ProcedureBehavior Checklist. 39<strong>The</strong> Memorial Symp<strong>to</strong>m Assessment Scale (MSAS) has been adapted <strong>for</strong> use in children aged 10<strong>to</strong> 18 years of age (see Figure 3-1). <strong>The</strong> MSAS can provide multidimensional in<strong>for</strong>mation aboutsymp<strong>to</strong>ms experienced by children. Its pediatric use <strong>to</strong> date, however, has been in the populationwith cancer <strong>and</strong> in the research setting rather than in clinical care. 44Additional <strong>to</strong>ols specifically <strong>for</strong> measuring pain in pediatric patients are presented at the end ofthis chapter in Figures 3-4 (a-d).IIICultural <strong>and</strong> Language BarriersSymp<strong>to</strong>m assessment <strong>and</strong> measurement can also present challenges in patients who differ inculture <strong>and</strong> language from the professionals providing their care. In cases where language barriersexist, meticulous attention should, where possible, be given <strong>to</strong> skilled translation. When measuringsymp<strong>to</strong>ms, only a few instruments have been shown <strong>to</strong> be reliable <strong>and</strong> valid across cultures <strong>and</strong>languages. 45, 46 Translation <strong>and</strong> appropriate symp<strong>to</strong>m measures must be used.In the clinical setting, health care professionals can use simple, face-valid symp<strong>to</strong>m measures <strong>to</strong>overcome language barriers. At the initial assessment the clinician can spend time with thepatient <strong>and</strong> an interpreter <strong>to</strong> develop a simple, two-language verbal rating scale <strong>for</strong> symp<strong>to</strong>ms,which can be kept by the patient’s bedside. To moni<strong>to</strong>r the level of distress <strong>and</strong> impact of interventions,such scales should address both symp<strong>to</strong>m intensity <strong>and</strong> relief. This approach will help<strong>to</strong> ensure that symp<strong>to</strong>m distress is minimized even when interpreters are not available. In addition,his<strong>to</strong>rytaking should explore cultural barriers <strong>to</strong> symp<strong>to</strong>m assessment <strong>and</strong> management.Substance Abuse His<strong>to</strong>ry or ProblemsClinicians frequently report that symp<strong>to</strong>m assessment is especially challenging when thepatient has a previous or current problem with substance abuse or addiction. In addition, difficultywith symp<strong>to</strong>m assessment also is common in situations in which the clinician is concernedthat a substance abuse problem may be present. In these situations, the assessment <strong>and</strong> managemen<strong>to</strong>f pain presents many difficult clinical issues. 47 However, as highlighted by Passik, etal., “virtually any drug that acts on the central nervous system <strong>and</strong> any route of drug administration,can be abused.” 48, 49 <strong>The</strong> implication is that assessment of substance abuse is importantwhen assessing a wide variety of symp<strong>to</strong>ms including pain, anxiety, depression, insomnia <strong>and</strong>many others. In cases where substance abuse is defined as a problem, experience <strong>and</strong> skill incaring <strong>for</strong> such patients can be invaluable as the issues involved in care can be very complex. 47U.S. Department of Health <strong>and</strong> Human Services • Health Resources <strong>and</strong> Services Administration • <strong>HIV</strong>/<strong>AIDS</strong> Bureau 57

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!